In Parker 2023 et al., on Locoregional analgesia in TPLO, what percentage of respondents reported that peripheral nerve blocks (PNB) were effective 81–100% of the time?
A. 45%
B. 55%
C. 78%
D. 62%
E. 91%
Answer: 78%
Explanation: Most respondents using PNB reported high confidence in its effectiveness (78% rated it 81–100% effective).
In Parker 2023 et al., on Locoregional analgesia in TPLO, which variable was significantly associated with increased preference for lumbosacral epidural (LE) over PNB?
A. Board-certification college
B. Body weight of dog
C. Time from board-certification
D. Geographic region of practice
E. Use of opioid additives
Answer: Time from board-certification
Explanation: LE was more common in diplomates >10 years post-certification, while newer diplomates preferred PNB (p < .001).
In Parker 2023 et al., on Locoregional analgesia in TPLO, what was the most frequently cited additive to bupivacaine in peripheral nerve blocks?
A. Morphine
B. Ketamine
C. Dexmedetomidine
D. Epinephrine
E. Medetomidine
Answer: Dexmedetomidine
Explanation: Dexmedetomidine was the most commonly selected additive for PNB, used by 85% of those adding any agent.
In Parker 2023 et al., on Locoregional analgesia in TPLO, what was the most commonly preferred locoregional anesthesia technique among anesthesiologists for dogs undergoing TPLO?
A. Lumbosacral epidural
B. Peri-incisional infiltration
C. Spinal block
D. Peripheral nerve block
E. No locoregional technique
Answer: Peripheral nerve block
Explanation: PNB was preferred by 79% of diplomates, making it the most frequently chosen locoregional technique for TPLO.
In Parker 2023 et al., on Locoregional analgesia in TPLO, which locoregional technique was rated as having the fewest adverse effects?
A. Lumbosacral epidural
B. Peri-incisional infiltration
C. Peripheral nerve block
D. Intrathecal morphine
E. Femoral nerve block only
Answer: Peripheral nerve block
Explanation: PNB was selected by 75% of respondents as having the lowest rate of adverse effects compared to LE and PI.